Elevated level of high-sensitivity C-reactive protein is important in determining prognosis in chronic heart failure

Güliz Kozdağ1, Gökhan Ertaş, Teoman Kiliç

  • 1Kocaeli University, Medical Faculty, Department of Cardiology, Kocaeli, Turkey.

Insights

High sensitivity C-reactive protein (hs-CRP) is a significant independent predictor of cardiac death in chronic heart failure (CHF) patients. Elevated hs-CRP levels can improve risk stratification for CHF patients, potentially guiding treatment decisions.

Area of Science:

  • Cardiology
  • Biomarkers
  • Prognostic Medicine

Background:

  • The prognostic value of high sensitivity C-reactive protein (hs-CRP) is established in coronary artery disease but less understood in chronic heart failure (CHF).
  • Limited data exists on the predictive importance of hs-CRP for outcomes in CHF patients.

Purpose of the Study:

  • To investigate the relationship between hs-CRP levels and prognosis in patients with chronic heart failure.
  • To determine if hs-CRP can serve as an independent predictor of cardiac mortality in CHF.

Main Methods:

  • A cohort of 258 CHF patients (74 female) with ischemic or non-ischemic etiology was followed for a mean of 17 months.
  • The primary endpoint was cardiac mortality.
  • hs-CRP, brain natriuretic peptide (BNP), and creatinine levels were measured and analyzed in relation to mortality.

Main Results:

  • Cardiac mortality occurred in 71 patients during follow-up.
  • Patients who died had significantly higher hs-CRP, BNP, and creatinine levels compared to survivors.
  • hs-CRP was identified as a significant independent predictor of cardiac death (HR: 1.1, 95% CI: 1.05-1.15, p<0.001).

Conclusions:

  • hs-CRP provides valuable additional prognostic information for risk stratification in CHF patients.
  • Elevated hs-CRP levels may help identify high-risk individuals within the CHF population.
  • These findings suggest hs-CRP could influence treatment strategies for chronic heart failure.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...